Clinical Trial Update: Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia [NA]

View source ↗

Summary

A clinical trial is evaluating the effects of nattokinase on inflammation and cardiovascular risk markers in patients with dyslipidemia and cardiovascular disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Dyslipidemia

Drugs mentioned

• Nattokinase (Nattokinase)

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Cardiovascular Diseases, Dyslipidemias | NA | Status: RECRUITING